Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

1 treatments under study, led by Proxera Psomed 20 Cream Proxera Psomed 40 Gel

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07545902Not ApplicableRecruiting

Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis

NCT02078297Completed

IL-17 Role in Variants of Psoriasis

Showing all 2 trials

Research Network

Common Treatments

  • Proxera Psomed 20 Cream Proxera Psomed 40 Gel1

Active Sponsors

  • Innovaderm Research Inc.1
  • Icim International Srl1

Top Investigators

Related Conditions

  • Elbow Psoriasis1
  • Plaque Type Psorisis1
  • Scalp Psoriasis1
  • Pustular Palmoplantar Psoriasis1
  • Lower Leg Psoriasis1

Activity Timeline